论文部分内容阅读
目的研究分析子宫内膜异位症患者在手术后给予米非司酮或孕三烯酮的辅助治疗效果,为临床治疗子宫内膜异位症给予参考。方法选择2008年1月至2011年12月我院收治的167例子宫内膜异位症患者为研究对象,随机分为两组。对照组患者在手术后给予米非司酮治疗,观察组患者给予孕三烯酮治疗,对比观察两组患者的疗效。结果观察组患者的治疗效果优于对照组,复发率低于对照组,P<0.05,差异有统计学意义;治疗6个月后两组患者的雌二醇水平比较差异明显,P<0.05,差异有统计学意义。结论在子宫内膜异位症患者手术后给予孕三烯酮的治疗效果更好,可以提高治疗效果且降低复发率。
Objective To study the effect of adjuvant treatment of mifepristone or gestrinone after operation in patients with endometriosis and to provide reference for the clinical treatment of endometriosis. Methods From January 2008 to December 2011, 167 patients with endometriosis admitted to our hospital were randomly divided into two groups. The patients in the control group were treated with mifepristone after operation, the patients in the observation group were given gestrinone, and the curative effect of the two groups was compared. Results The therapeutic effect of the observation group was better than that of the control group, the recurrence rate was lower than that of the control group, P <0.05, the difference was statistically significant; after 6 months of treatment, the two groups of patients showed significant difference in estradiol level, P <0.05, The difference was statistically significant. Conclusion The treatment of patients with endometriosis after gestrinone treatment is better, which can improve the therapeutic effect and reduce the recurrence rate.